This is a routine marketing press release with no financial or operational updates. Monitor Medifast's next quarterly earnings release for revenue trends and subscriber metrics.
Price Chart
Executive Summary
Medifast issued a press release highlighting five signs of poor metabolic health and promoting its Trilivy metabolic health system, including a clinical trial showing 14% visceral fat reduction and 98% lean mass retention at 16 weeks. This is a brand-awareness and educational marketing piece, not a financial disclosure — no revenue, earnings, guidance, or material corporate events were reported.
Key Facts
- Press release focuses on metabolic health education and Trilivy product promotion
- No financial results, guidance, or material corporate events disclosed
- Clinical trial cited: Reset 5 & 1 Plan showed 14% visceral fat reduction and 98% lean mass retention at 16 weeks
- Trilivy system includes Metabolic Synchronization, MetaVantage Reset Formula, and Habits of Health program
- Medifast (NYSE: MED) is the parent company
Financial Impact
No financial data disclosed in the press release
Risk Factors
- No new financial or operational data to assess business performance
- Marketing content does not indicate changes in revenue, margins, or growth trajectory
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3372732 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 8-K | — | awaiting T+5 | — | — |
Oct 15, 2026 11d ago | Press Release | $12.06 $12.17 | ▲ +0.91% | ▲ +1.93% | $12.11 (+0.41%) |
Oct 6, 2026 20d ago | Press Release | $11.51 $11.67 | ▲ +1.39% | ▲ +1.53% | $12.11 (+5.21%) |
Oct 1, 2026 25d ago | Press Release | $11.43 $11.43 | · 0.00% | ▼ −1.30% | $12.11 (+5.95%) |
Aug 28, 2026 8w ago | Insider Buy | $12.18 $12.63 | ▲ +3.69% | ▲ +3.59% | $12.11 (−0.57%) |
Aug 26, 2026 8w ago | Insider Buy | $12.22 $12.67 | ▲ +3.68% | ▲ +3.80% | $12.11 (−0.90%) |
Aug 21, 2026 9w ago | Insider Buy | $11.95 $12.18 | ▲ +1.92% | ▲ +1.45% | $12.11 (+1.34%) |
Jul 17, 2026 14w ago | 8-K | $10.26 $9.45 | ▼ −7.89% | ▼ −7.21% | $12.11 (+18.03%) |
Jun 1, 2026 21w ago | 8-K | $12.70 $12.10 | ▼ −4.72% | ▼ −1.97% | $12.11 (−4.65%) |
May 26, 2026 21w ago | 8-K | $12.72 $12.36 | ▼ −2.83% | ▼ −4.04% | $12.11 (−4.80%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers